Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28158212 | 0.92 | LMNA (0.63) | LMNA | |
| SCHEMBL26025831 | 0.85 | LMNA (0.36) | LMNA | |
| SCHEMBL8588148 | 0.81 | — | — | |
| SCHEMBL20872363 | 0.81 | THRB (0.42) | LMNAMAPTTSHR | |
| SCHEMBL8419012 | 0.80 | TSHR (0.35) | LMNAMAPTTSHR | |
| SCHEMBL19883178 | 0.79 | TDP1 (0.33) | LMNAMAPT | |
| SCHEMBL17103150 | 0.79 | LMNA (0.32) | LMNAMAPT | |
| SCHEMBL20872366 | 0.77 | — | — | |
| SCHEMBL15354756 | 0.77 | — | — | |
| SCHEMBL17103148 | 0.77 | MAPT (0.31) | LMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122029143-A | Method for producing 1, 3-butanediol and products thereof | 戈达瓦里生物炼制有限责任公司 | 2026-05-12 | — | — | CN | claimed |
| CN-122029143-A | Method for producing 1, 3-butanediol and products thereof | 戈达瓦里生物炼制有限责任公司 | 2026-05-12 | — | — | CN | disclosed |
| US-20250241356-A1 | ORAL COMPOSITION COMPRISING RECEPTOR MODULATOR | DANIEL MICHAEL S (US) | 2025-07-31 | — | — | US | disclosed |
| EP-4324341-B1 | AEROSOLISABLE FORMULATION | NICOVENTURES TRADING LTD (GB) | 2025-07-09 | — | — | EP | disclosed |
| EP-4543230-A1 | AEROSOLISABLE FORMULATION | Nicoventures Trading Limited (GB) | 2025-04-30 | — | — | EP | disclosed |
| EP-4324341-A2 | AEROSOLISABLE FORMULATION | Nicoventures Trading Limited (GB) | 2024-02-21 | — | — | EP | disclosed |
| EP-3873249-B1 | AEROSOLISABLE FORMULATION | NICOVENTURES TRADING LTD (GB) | 2024-02-14 | — | — | EP | disclosed |
| WO-2023247962-A1 | AEROSOLISABLE FORMULATION | Nicoventures Trading Limited (GB) | 2023-12-28 | — | — | WO | disclosed |
| CN-113163841-B | Aerosol formulation | 尼科创业贸易有限公司 | 2022-10-04 | — | — | CN | disclosed |
| US-20220071267-A1 | AEROSOLIZABLE FORMULATION | Nicoventures Trading Limited (GB) | 2022-03-10 | — | — | US | disclosed |
| EP-3873249-A1 | AEROSOLISABLE FORMULATION | Nicoventures Trading Limited (GB) | 2021-09-08 | — | — | EP | disclosed |